Emcutix launches Flawlizo – targeted solutions for quick acne relief
Overview
Emcutix Biopharmaceuticals Ltd., a wholly owned subsidiary of Emcure Pharmaceuticals Ltd., announces its entry into the anti-acne skincare category with the launch of Flawlizo Xpert Acne Care. The range aims to redefine acne care with a science-driven and targeted approach.
Flawlizo Launches Science-Backed Skincare for Acne-Prone Skin
• The range includes Flawlizo Acne Spot Corrector, a fast-acting biphasic solution proven to visibly reduce early breakouts within three to five days, and Flawlizo acne care moisturizing gel, a non-comedogenic formulation enriched with natural extracts to hydrate acne-prone skin without clogging pores.
• Both products are developed for safe, effective, and convenient everyday use, catering to the growing demand of science backed skincare solutions.
Flawlizo Launches Science-Backed Skincare for Acne-Prone Skin
• Flawlizo Xpert Acne Care range also comprises five prescriptions only products formulated with Tretinoin – a gold-standard active pharmaceutical ingredient (API) sourced from Italy.
• These products are manufactured at the facility of Encube Ethicals Private Limited, a US FDA registered global supplier.
• Encube is also recognized for having the largest manufacturing capabilities for pharmaceutical topical formulations.
CEO, Emcutix Biopharmaceuticals on the new range
• Speaking about the new range, Sathya Narayanan, CEO, Emcutix Biopharmaceuticals Ltd. said, “At Emcutix, we are committed to bridging every day skincare needs with clinical efficacy. With the Flawlizo range, we aim at delivering science-led, consumer-friendly products that empower individuals to manage acne effortlessly.”
• The introduction of this range is a testament to our vision of making high-quality dermatology products accessible across India.”
Emcutix Expands Skincare Portfolio with PRX-PLUS Launch
• Emcutix Biopharmaceuticals Ltd., backed by Emcure Pharmaceuticals Ltd., is a dermatology company committed to delivering innovative skincare and aesthetic solutions in India.
• Established in 2024, Emcutix aims to become a world-class leader by introducing groundbreaking treatments, globally recognized brands, and a differentiated product portfolio spanning therapeutic and aesthetic dermatology.
Let’s apply Data-Driven Pricing to Your APIs
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions!
Learn More!